🇺🇸 FDA
Patent

US 10722478

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

granted A61KA61K31/135A61K31/137

Quick answer

US patent 10722478 (Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine) held by TONIX PHARMA LIMITED expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/135, A61K31/137, A61K45/06, A61K9/0053